Holly McAleese

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

N. Tolia, M. Murphy, M. Holbrook, 2023, Cell Reports.

Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine

N. Tolia, P. Duffy, O. Muratova, 2023, npj Vaccines.

A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle

N. Tolia, C. Long, K. Miura, 2023, NPJ vaccines.

Structure-based design of a strain transcending AMA1-RON2L malaria vaccine

N. Tolia, C. Long, K. Miura, 2023, Nature communications.

RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination

N. Tolia, N. Salinas, Sachy Orr-Gonzalez, 2024, Antiviral Research.